/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Intensity Therapeutics Inc Share Price Today: Live Updates & Key Insights

Intensity Therapeutics Inc share price today is $5.98, up -5.53%. The stock opened at $6.25 against the previous close of $6.33, with an intraday high of $6.29 and low of $5.99.

Intensity Therapeutics Inc Share Price Chart

style
pb-0

Intensity Therapeutics Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Intensity Therapeutics Inc Share Price Performance

$5.98 -0.0553(-5.53%) INTS at 23 Mar 2026 01:40 PM Biotechnology
Lowest Today 5.99
Highest Today 6.29
Today’s Open 6.25
Prev. Close 6.33
52 Week High 54.50
52 Week Low 4.63
Day’s Range: Low 5.99 High 6.29
52-Week Range: Low 4.63 High 54.50
1 day return -
1 Week return -3.7
1 month return +2.93
3 month return +1348.32
6 month return +2202.35
1 year return +207.73
3 year return +2.75
5 year return -
10 year return -

Intensity Therapeutics Inc Institutional Holdings

Vanguard Group Inc 1.02

Sentinus, LLC 0.76

Geode Capital Management, LLC 0.73

Vanguard Institutional Extnd Mkt Idx Tr 0.66

Fidelity Extended Market Index 0.43

Mesirow Fin Investmt Mgmt Intl Equity 0.40

Legacy Advisors, LLC 0.24

UBS Group AG 0.22

Brown Advisory Holdings Inc 0.21

Stonebridge Financial Group, LLC 0.12

Fidelity Total Market Index 0.12

NT Ext Equity Mkt Idx Fd - L 0.11

Jane Street Group LLC 0.10

Fidelity Series Total Market Index 0.10

Warberg Asset Management LLC 0.09

Sigma Planning Corp 0.09

IHT Wealth Management, LLC 0.08

Citigroup Inc 0.07

EWA, LLC 0.07

Spartan Total Market Index Pool G 0.06

TWO SIGMA SECURITIES, LLC 0.06

One Charles Private Wealth Services, LLC 0.05

Blair William & Co 0.05

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.04

Virtu Financial LLC 0.04

Goss Wealth Management LLC 0.04

Scientech Research LLC 0.04

Northern Trust Extended Eq Market Idx 0.01

Fidelity Nasdaq Composite Index 0.01

NT Ext Equity Mkt Idx Fd - NL 0.01

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.01

Spartan Extended Market Index Pool F 0.00

NT US Market Cap Idx Fd - L 0.00

Northern Trust Wilshire 5000 0.00

Fidelity U.S. Equity Index Ins Trust 0.00

Intensity Therapeutics Inc Market Status

Strong Buy: 1

Buy: 2

Hold: 2

Sell: 0

Strong Sell: 0

Intensity Therapeutics Inc Fundamentals

Market Cap 15.15 M

PB Ratio 2.0981

PE Ratio 0.0

Enterprise Value 8.20 M

Total Assets 4.78 M

Volume 48434

Intensity Therapeutics Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-8877099 -8.9M, FY22:-7451058 -7.5M, FY21:-7892991 -7.9M, FY20:-5956471 -6.0M, FY19:-5229129 -5.2M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-6000 -0.0M, Q2/2025:-7000 -0.0M, Q1/2025:-6000 -0.0M, Q3/2024:null 0.0M, Q2/2024:-6000 -0.0M

Quarterly Net worth Q3/2025:-2671000 -2.7M, Q2/2025:-2537000 -2.5M, Q1/2025:-3347000 -3.3M, Q3/2024:-3513000 -3.5M, Q2/2024:-4971000 -5.0M

About Intensity Therapeutics Inc & investment objective

Company Information Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.

Organisation Biotechnology

Employees 5

Industry Biotechnology

CEO Mr. Lewis H. Bender M.A., M.B.A., M.S.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

Intensity Therapeutics Inc FAQs

What is the share price of Intensity Therapeutics Inc today?

The current share price of Intensity Therapeutics Inc is $5.98.

Can I buy Intensity Therapeutics Inc shares in India?

Yes, Indian investors can buy Intensity Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Intensity Therapeutics Inc shares in India?

You can easily invest in Intensity Therapeutics Inc shares from India by:

Can I buy fractional shares of Intensity Therapeutics Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Intensity Therapeutics Inc?

Intensity Therapeutics Inc has a market cap of $15.15 M.

In which sector does Intensity Therapeutics Inc belong?

Intensity Therapeutics Inc operates in the Biotechnology sector.

What documents are required to invest in Intensity Therapeutics Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Intensity Therapeutics Inc?

The PE ratio of Intensity Therapeutics Inc is N/A and the PB ratio is 2.10.